Redefining the Tumor Microenvironment with Emerging Therapeutic Strategies

Overview

Journal Oncol Res

Specialty Oncology

Date 2024 Oct 25

PMID 39449800

Authors

Suling Xu

Xiao Li

Wenxue Ma

Affiliations

Soon will be listed here.

Abstract

The environment surrounding a tumor, known as the tumor microenvironment (TME), plays a role in how cancer progresses and responds to treatment. It poses both challenges and opportunities for improving cancer therapy. Recent progress in understanding the TME complexity and diversity has led to approaches for treating cancer. This perspective discusses the strategies for targeting the TME, such as adjusting networks using extracellular vesicles to deliver drugs and enhancing immune checkpoint inhibitors (ICIS) through combined treatments. Furthermore, it highlights adoptive cell transfer (ACT) therapies as an option for tumors. By studying how components of the TME interact and utilizing technologies like single-cell RNA sequencing and spatial transcriptomics, we can develop more precise and efficient treatments for cancer. This article emphasizes the need to reshape the TME to boost antitumor immunity and overcome resistance to therapy, providing guidance for research and clinical practices in precision oncology.

References

Ma C, Yang C, Peng A, Sun T, Ji X, Mi J . Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer. 2023; 22(1):170. PMC: 10571470. DOI: 10.1186/s12943-023-01876-x. View

Xiao J, Yu X, Meng F, Zhang Y, Zhou W, Ren Y . Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer. Cell Death Dis. 2024; 15(5):326. PMC: 11087651. DOI: 10.1038/s41419-024-06598-6. View

Shah V, Panchal V, Shah A, Vyas B, Agrawal S, Bharadwaj S . Immune checkpoint inhibitors in metastatic melanoma therapy (Review). Med Int (Lond). 2024; 4(2):13. PMC: 10895472. DOI: 10.3892/mi.2024.137. View

Zhang T, Ren Y, Yang P, Wang J, Zhou H . Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis. 2022; 13(10):897. PMC: 9596464. DOI: 10.1038/s41419-022-05351-1. View

Sazeides C, Le A . Metabolic Relationship Between Cancer-Associated Fibroblasts and Cancer Cells. Adv Exp Med Biol. 2021; 1311:189-204. PMC: 9703248. DOI: 10.1007/978-3-030-65768-0_14. View

Bhat A, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad C . Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy. Cancer Commun (Lond). 2022; 42(8):689-715. PMC: 9395317. DOI: 10.1002/cac2.12295. View

Zheng J, Wang X, Yu J, Zhan Z, Guo Z . IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy. Front Oncol. 2022; 12:997665. PMC: 9549173. DOI: 10.3389/fonc.2022.997665. View

Testa A, Venturelli E, Brizzi M . Extracellular Vesicles as a Novel Liquid Biopsy-Based Diagnosis for the Central Nervous System, Head and Neck, Lung, and Gastrointestinal Cancers: Current and Future Perspectives. Cancers (Basel). 2021; 13(11). PMC: 8200014. DOI: 10.3390/cancers13112792. View

Lopez K, Lai S, Lopez Gonzalez E, Davila R, Shuck S . Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression. Front Cell Dev Biol. 2023; 11:1154576. PMC: 10071009. DOI: 10.3389/fcell.2023.1154576. View

10.

Carvalho T, Di Molfetta D, Greco M, Koltai T, Alfarouk K, Reshkin S . Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches. Cancers (Basel). 2021; 13(23). PMC: 8657427. DOI: 10.3390/cancers13236135. View

11.

Arima Y, Matsueda S, Saya H . Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue. Cancers (Basel). 2023; 15(9). PMC: 10177529. DOI: 10.3390/cancers15092536. View

12.

Ahmed R, Zaman T, Chowdhury F, Mraiche F, Tariq M, Ahmad I . Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues. Int J Mol Sci. 2022; 23(6). PMC: 8955933. DOI: 10.3390/ijms23063042. View

13.

Fan G, Xie T, Li L, Tang L, Han X, Shi Y . Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma. NPJ Precis Oncol. 2024; 8(1):75. PMC: 10960828. DOI: 10.1038/s41698-024-00564-3. View

14.

DePeaux K, Rivadeneira D, Lontos K, Dean V, Gunn W, Watson M . An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment. J Exp Med. 2023; 220(10). PMC: 10407786. DOI: 10.1084/jem.20230053. View

15.

Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z . Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023; 8(1):124. PMC: 10017761. DOI: 10.1038/s41392-023-01382-y. View

16.

Ageenko A, Vasileva N, Richter V, Kuligina E . Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma. Int J Mol Sci. 2024; 25(4). PMC: 10889383. DOI: 10.3390/ijms25042042. View

17.

Zhu J, Zhang K, Chen Y, Ge X, Wu J, Xu P . Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer. J Transl Med. 2024; 22(1):563. PMC: 11167806. DOI: 10.1186/s12967-024-05307-3. View

18.

Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y . Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct Target Ther. 2024; 9(1):132. PMC: 11102923. DOI: 10.1038/s41392-024-01823-2. View

19.

Kourko O, Seaver K, Odoardi N, Basta S, Gee K . IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer. Front Oncol. 2019; 9:969. PMC: 6797860. DOI: 10.3389/fonc.2019.00969. View

20.

Pagano G, Fernandez Botana I, Wierz M, Roessner P, Ioannou N, Zhou X . Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia. Haematologica. 2023; 108(11):3011-3024. PMC: 10620579. DOI: 10.3324/haematol.2022.282474. View